BIA Separations builds new upstream processing facility

The expansion will provide a single source of expertise for scaled up production of complex biologics for gene therapy and vaccines

picture of

Breaking News

PCI joins forces with CSP Technologies

Exclusive collaboration for breakthrough packaging solution that enhance shelf life and speed-to-market for ...

Wacker invests in biotech site

The German chemical group has enhanced its biopharmaceutical production facilities with new equipment

Lab Innovations announces CPD-certified conference programme

The two-day agenda of free presentations boasts over 35 hours of CPD-accredited content focused on science and new ...

Barrier systems: taking a safety first approach to processing highly potent pharmaceuticals

To effectively protect humans and products from each other, demand for closed barrier systems such as cRABS and ...

Cell and Gene Therapy Catapult centre gets green light

The independent cell and gene therapy researcher and industry partner, working with Innovate UK, has been granted new ...

PCI inks agreement to acquire Sherpa Clinical Packaging

The move aims to expand the biopharmaceutical service provider's operations to the West Coast of the US

HydroGienic: High purity water all along the pipework

The Honeyman Group is reaping the rewards of its award-winning HydroGienic water supply system. Chairman Trevor ...

Pall and Celltheon form strategic biotherapeutics partnership

This partnership will deliver integrated manufacturing solutions for customers developing biotherapeutics

Sartorius and Repligen collaborate on perfusion-enabled bioreactors

Joint technology to control cell growth, fluid management and cell retention would simplify development and cGMP ...

Adequately establishing contamination risk in drug products

Recent changes within the United States Pharmacopoeia (USP) and European Pharmacopoeia (EP) put emphasis on risk ...

Brexit trade bill: Not yet

The UK has decided it will continue to be involved with the European Medicines Agency (EMA) after Brexit. Paul Brooks, ...

Inside Patheonís new flexible pharmaceutical development facilities

In the pharmaceutical sector, flexible facilities are in demand as new niche therapies replace the traditional ...

Brexit could force UK to relinquish control of pharma regulations

According to GlobalData, recently released Government technical papers indicate UK will be forced to relinquish control ...

SGD Pharma upgrades Chinese plant

The French company has completely redesigned and enlarged the ISO 8 cleanroom